360 related articles for article (PubMed ID: 24416825)
41. Frontotemporal dementia: from genetics to therapeutic approaches.
Buccellato FR; D'Anca M; Tartaglia GM; Del Fabbro M; Galimberti D
Expert Opin Investig Drugs; 2024 Jun; 33(6):561-573. PubMed ID: 38687620
[TBL] [Abstract][Full Text] [Related]
42. Review: Neuropathology of non-tau frontotemporal lobar degeneration.
Neumann M; Mackenzie IRA
Neuropathol Appl Neurobiol; 2019 Feb; 45(1):19-40. PubMed ID: 30357887
[TBL] [Abstract][Full Text] [Related]
43. Phenotypic signatures of genetic frontotemporal dementia.
Rohrer JD; Warren JD
Curr Opin Neurol; 2011 Dec; 24(6):542-9. PubMed ID: 21986680
[TBL] [Abstract][Full Text] [Related]
44. A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques.
Moreno F; Rabinovici GD; Karydas A; Miller Z; Hsu SC; Legati A; Fong J; Schonhaut D; Esselmann H; Watson C; Stephens ML; Kramer J; Wiltfang J; Seeley WW; Miller BL; Coppola G; Grinberg LT
Acta Neuropathol Commun; 2015 Apr; 3():19. PubMed ID: 25853458
[TBL] [Abstract][Full Text] [Related]
45. Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.
Galimberti D; Scarpini E
Int J Clin Exp Med; 2010 May; 3(2):129-43. PubMed ID: 20607039
[TBL] [Abstract][Full Text] [Related]
46. Plasma proteome profiling identifies changes associated to AD but not to FTD.
Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE
Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219
[TBL] [Abstract][Full Text] [Related]
47. Frontotemporal dementia: An updated overview.
Mohandas E; Rajmohan V
Indian J Psychiatry; 2009 Jan; 51 Suppl 1(Suppl1):S65-9. PubMed ID: 21416021
[TBL] [Abstract][Full Text] [Related]
48. A new subtype of frontotemporal lobar degeneration with FUS pathology.
Neumann M; Rademakers R; Roeber S; Baker M; Kretzschmar HA; Mackenzie IR
Brain; 2009 Nov; 132(Pt 11):2922-31. PubMed ID: 19674978
[TBL] [Abstract][Full Text] [Related]
49. Mutation Analysis of the Genes Linked to Early Onset Alzheimer's Disease and Frontotemporal Lobar Degeneration.
Luukkainen L; Helisalmi S; Kytövuori L; Ahmasalo R; Solje E; Haapasalo A; Hiltunen M; Remes AM; Krüger J
J Alzheimers Dis; 2019; 69(3):775-782. PubMed ID: 31127772
[TBL] [Abstract][Full Text] [Related]
50. The severity of behavioural symptoms in FTD is linked to the loss of GABRQ-expressing VENs and pyramidal neurons.
Gami-Patel P; Scarioni M; Bouwman FH; Boon BDC; van Swieten JC; Brain Bank N; Rozemuller AJM; Smit AB; Pijnenburg YAL; Hoozemans JJM; Dijkstra AA
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12798. PubMed ID: 35152451
[TBL] [Abstract][Full Text] [Related]
51. Frontotemporal dementia: from molecular mechanisms to therapy.
Haass C; Neumann M
J Neurochem; 2016 Aug; 138 Suppl 1():3-5. PubMed ID: 27502123
[TBL] [Abstract][Full Text] [Related]
52. The Genetics of Monogenic Frontotemporal Dementia.
Takada LT
Dement Neuropsychol; 2015; 9(3):219-229. PubMed ID: 29213965
[TBL] [Abstract][Full Text] [Related]
53. Frontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation.
Redaelli V; Salsano E; Colleoni L; Corbetta P; Tringali G; Del Sole A; Giaccone G; Rossi G
J Alzheimers Dis; 2018; 63(1):195-201. PubMed ID: 29578490
[TBL] [Abstract][Full Text] [Related]
54. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.
Chitramuthu BP; Bennett HPJ; Bateman A
Brain; 2017 Dec; 140(12):3081-3104. PubMed ID: 29053785
[TBL] [Abstract][Full Text] [Related]
55. Rapidly progressive Fronto-temporal dementia (FTD) associated with Frontotemporal lobar degeneration (FTLD) in the presence of Fused in Sarcoma (FUS) protein: a rare, sporadic, and aggressive form of FTD.
Bradfield NI; McLean C; Drago J; Darby DG; Ames D
Int Psychogeriatr; 2017 Oct; 29(10):1743-1746. PubMed ID: 28660843
[TBL] [Abstract][Full Text] [Related]
56. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.
Taipa R; Tuna A; Damásio J; Pinto PS; Cavaco S; Pereira S; Milterberger-Miltenyi G; Galimberti D; Melo-Pires M
J Alzheimers Dis; 2012; 30(1):83-90. PubMed ID: 22366770
[TBL] [Abstract][Full Text] [Related]
57. A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.
Nicolas G; Sévigny M; Lecoquierre F; Marguet F; Deschênes A; Del Pelaez MC; Feuillette S; Audebrand A; Lecourtois M; Rousseau S; Richard AC; Cassinari K; Deramecourt V; Duyckaerts C; Boland A; Deleuze JF; Meyer V; Clarimon Echavarria J; Gelpi E; Akiyama H; Hasegawa M; Kawakami I; Wong TH; Van Rooij JGJ; Van Swieten JC; Campion D; Dutchak PA; Wallon D; Lavoie-Cardinal F; Laquerrière A; Rovelet-Lecrux A; Sephton CF
Acta Neuropathol Commun; 2022 Feb; 10(1):20. PubMed ID: 35151370
[TBL] [Abstract][Full Text] [Related]
58. Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues.
Ferrari R; Manzoni C; Hardy J
Neurobiol Aging; 2019 Jun; 78():98-110. PubMed ID: 30925302
[TBL] [Abstract][Full Text] [Related]
59. Modifiers of GRN-Associated Frontotemporal Lobar Degeneration.
Wauters E; Van Mossevelde S; Van der Zee J; Cruts M; Van Broeckhoven C
Trends Mol Med; 2017 Oct; 23(10):962-979. PubMed ID: 28890134
[TBL] [Abstract][Full Text] [Related]
60. New Approaches to the Treatment of Frontotemporal Dementia.
Neylan KD; Miller BL
Neurotherapeutics; 2023 Jul; 20(4):1055-1065. PubMed ID: 37157041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
